Researchers at University of Manchester Target Schizophrenia [Multisite randomised controlled trial of a novel dialogical therapy in comparison to treatment as usual in adults with distressing and persistent auditory hallucinations: study...].

The article focuses on a feasibility and acceptability trial of a new intervention called Talking With Voices (TWV) aimed at addressing auditory hallucinations in individuals with serious mental health problems (SMHP), particularly those with schizophrenia. The study, conducted by researchers from the University of Manchester, highlights the limitations of current treatments like antipsychotic medication and cognitive behavioral therapy (CBT), which often do not address trauma's role in voice onset. The upcoming multisite randomized controlled trial will evaluate TWV's clinical efficacy and its psychological mechanisms in a diverse population experiencing distressing voices, with plans to recruit 296 participants across four UK sites. The primary outcome will assess recovery processes, while secondary outcomes will include voice severity and trauma-related dimensions. [Extracted from the article]